Fortress Biotech, Inc.FBIONASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-62.22%
↓ 69% below average
Average (39q)
-36.90%
Historical baseline
Range
High:246.32%
Low:-1040.95%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -62.22% |
| Q2 2025 | 246.32% |
| Q1 2025 | -56.45% |
| Q4 2024 | 47.42% |
| Q3 2024 | -17.53% |
| Q2 2024 | 28.99% |
| Q1 2024 | -66.15% |
| Q4 2023 | -83.92% |
| Q3 2023 | 79.64% |
| Q2 2023 | -15.04% |
| Q1 2023 | 20.08% |
| Q4 2022 | -19.71% |
| Q3 2022 | -5.41% |
| Q2 2022 | -35.51% |
| Q1 2022 | 50.07% |
| Q4 2021 | -51.89% |
| Q3 2021 | -487.86% |
| Q2 2021 | 59.93% |
| Q1 2021 | -66.61% |
| Q4 2020 | 65.94% |
| Q3 2020 | -16.77% |
| Q2 2020 | -7.63% |
| Q1 2020 | 20.15% |
| Q4 2019 | -21.39% |
| Q3 2019 | 2.57% |
| Q2 2019 | -1040.95% |
| Q1 2019 | 105.59% |
| Q4 2018 | -49.54% |
| Q3 2018 | 23.01% |
| Q2 2018 | -2.82% |
| Q1 2018 | -101.84% |
| Q4 2017 | 61.60% |
| Q3 2017 | -56.15% |
| Q2 2017 | -44.93% |
| Q1 2017 | 31.26% |
| Q4 2016 | -34.28% |
| Q3 2016 | -4.03% |
| Q2 2016 | -2.24% |
| Q1 2016 | -1.40% |
| Q4 2015 | 33.73% |